Meyka Pro banner
Artivion, Inc.

Artivion, Inc. (AORT) Stock Overview

Explore Artivion, Inc.’s financial performance, market position, analyst ratings, and future outlook.

AORTNYSE
HealthcareMedical - Devices
$28.41
$0.23(0.80%)
U.S. Market opens in 3h 2m

Artivion, Inc. (AORT)

Meyka AI Score

Z

Key Financials

Market Cap1.4B
P/E Ratio-480.29
EPS (TTM)$0.60
ROE-0.01%
Fundamental Analysis

AI Price Forecasts

1 Month$42.10
3 Months$26.49
1 Year Target$43.84

AORT Stock Analysis & Investment Overview (NYSE)

Our AI-powered analysis of Artivion, Inc. (NYSE: AORT) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Artivion, Inc.'s NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of AORT on the NYSE shows an RSI of 64.35, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $43.84 for the NYSE listing.

Key metrics behind Artivion, Inc.'s NYSE-traded stock include a P/E ratio of -480.29 and a market capitalization of 1.4B. Combined with our AI analysis, these give both institutional and retail investors a clear view of AORT on the NYSE.

Price Performance (NYSE: AORT)

1-Day Change
-0.73%
5-Day Change
5.69%
1-Month Change
18.31%
3-Month Change
27.89%
6-Month Change
-22.32%
Year-to-Date (YTD) Change
-37.67%
1-Year Change
-34.99%
3-Year Change
65.58%
5-Year Change
13.09%
All-Time (Max) Change
255.38%

Contact Information

770 419 3355
1655 Roberts Boulevard N.W., Kennesaw, GA, 30144

Company Facts

18,000 Employees
IPO DateFeb 12, 1993
CountryUS
Actively Trading

Frequently Asked Questions